These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7553496)

  • 1. The dilemma of hereditary prostate cancer.
    Nickel JC
    CMAJ; 1995 Oct; 153(7):935-8. PubMed ID: 7553496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A model of prostate-specific antigen screening outcomes for low- to high-risk men: information to support informed choices.
    Howard K; Barratt A; Mann GJ; Patel MI
    Arch Intern Med; 2009 Sep; 169(17):1603-10. PubMed ID: 19786680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The early detection of prostate cancer. Prostate Cancer Alliance of Canada.
    Can Oncol Nurs J; 1998 Nov; 8(4):262-4. PubMed ID: 9866477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening and early detection for prostate cancer.
    Magoha GA
    East Afr Med J; 1997 Oct; 74(10):664-7. PubMed ID: 9529752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of subclinical cancers by prostate-specific antigen screening in asymptomatic men from high-risk prostate cancer families.
    Matikainen MP; Schleutker J; Mörsky P; Kallioniemi OP; Tammela TL
    Clin Cancer Res; 1999 Jun; 5(6):1275-9. PubMed ID: 10389909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for prostate cancer in asymptomatic men: clinical, legal, and ethical implications.
    Gerard MJ; Frank-Stromborg M
    Oncol Nurs Forum; 1998 Oct; 25(9):1561-9. PubMed ID: 9802052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors, prevention and early detection of prostate cancer.
    Loeb S; Schaeffer EM
    Prim Care; 2009 Sep; 36(3):603-21. PubMed ID: 19616157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early detection of prostate cancer. Role of prostate-specific antigen.
    Prabhakaran VM
    Can Fam Physician; 1996 Apr; 42():709-12. PubMed ID: 8653039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of informed consent on patient interest in prostate-specific antigen screening.
    Wolf AM; Nasser JF; Wolf AM; Schorling JB
    Arch Intern Med; 1996 Jun; 156(12):1333-6. PubMed ID: 8651843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing level of prostate-specific antigen and prostate cancer risk factors among 193 men examined in screening procedure.
    Opalińska E; Michalak A; Stoma F; Latalski M; Goniewicz M
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):57-63. PubMed ID: 15323167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The unreasonableness of prostate-cancer screening and the ethical problems pertaining to its investigation].
    Bonneux L
    Ned Tijdschr Geneeskd; 2005 Apr; 149(18):966-71. PubMed ID: 15903036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current controversies in screening: cholesterol, breast cancer, and prostate cancer.
    Sox HC
    Mt Sinai J Med; 1999 Mar; 66(2):91-101. PubMed ID: 10100412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How to use PSA to screen for prostate cancer.
    Little B; Young M
    Int J Clin Pract; 2003; 57(1):40-2. PubMed ID: 12587941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prostatic specific antigen in practice in 1997].
    Salomon L; Colombel M; Patard JJ; Chopin D; Abbou CC
    Ann Urol (Paris); 1998; 32(2):69-72. PubMed ID: 9599634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early detection of prostate cancer. Decreasing the mortality rate.
    Oesterling JE
    Minn Med; 1996 Apr; 79(4):46-9. PubMed ID: 8637492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prostate cancer screening].
    Villers A; Rébillard X; Soulié M; Davin JL; Coloby P; Moreau JL; Mejean A; Irani J; Coulange C; Mangin P;
    Prog Urol; 2003 Apr; 13(2):209-14. PubMed ID: 12765053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions?
    O'Dell KJ; Volk RJ; Cass AR; Spann SJ
    J Fam Pract; 1999 Sep; 48(9):682-8. PubMed ID: 10498074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidental acute prostatic inflammation is associated with a lower percentage of free prostate-specific antigen than other benign conditions of the prostate: a prospective screening study.
    Rowe EW; Laniado ME; Walker MM; Anup P
    BJU Int; 2006 May; 97(5):1039-42. PubMed ID: 16643488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for prostate cancer.
    Brawley OW; Ankerst DP; Thompson IM
    CA Cancer J Clin; 2009; 59(4):264-73. PubMed ID: 19564245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Educating men about prostate cancer screening. A randomized trial of a mailed pamphlet.
    Wilt TJ; Paul J; Murdoch M; Nelson D; Nugent S; Rubins HB
    Eff Clin Pract; 2001; 4(3):112-20. PubMed ID: 11434074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.